CCL2 and cancer: Monocytes migrate into peritoneal lesions using the C-C chemokine ligand 2 (CCL2) derived from CAFs and differentiate into the M2 phenotype by macrophage colony-stimulating factor (M-CSF) and IL-6 secreted from CAFs and cancer cells [35].